Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
Analysing the compliance imperatives for both US pharma and the strategic considerations for Chinese biotech navigating the cross-border environment.
The move comes amid a surge in patients self-diagnosing using online tools like chatbots.
More than 60 tech companies pledge to work on interoperability and more user-friendly apps to create a more efficient healthcare experience for patients.